New drug ENA-001 tested for safety in first human study
Knowledge-focused
Recruiting now
This early-stage study tests a new drug called ENA-001 in 36 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose either through a vein or as a shot. The goal is to gather safety information before testing it in patients with respi…
Phase: PHASE1 • Sponsor: Enalare Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC